KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024)

$59.8M

Net Income/Loss (FY2024)

-$113.8M

Total Assets (FY2024)

$295.7M

Total Equity (FY2024)

$205.4M

Cash Flows from Operating Activities (FY2024)

-$77.6M

Source: KESTRA MEDICAL TECHNOLOGIES, LTD. 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.